Browse the corpus

REFERENCES Briars LA, Hilao JJ, and Kraus DM, “A Review of Pediatric Human Immunodeficiency Virus Infection,” Journal of Pharmacy Practice , 2004, 17(6):407-31. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, “Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, Department of Health and Human Services,” October 14, 2011;1-167. Available at file://aidsinfo.nih.gov DHHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, Department of Health and Human Services," August 11, 2011;1-268. Available at file://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf DHHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, "Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States," September 14, 2011; 1-207. Available at file://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf Goldsmith DR and Perry CM, “Atazanavir,” Drugs , 2003, 63(16):1679-93. [PubMed 12904086 ] Morris JL and Kraus DM, "New Antiretroviral Therapies for Pediatric HIV Infection," J Pediatr Pharmacol Ther , 2005, 10:215-47. Musial BL, Chojnacki JK, and Coleman CI, “Atazanavir: A New Protease Inhibitor to Treat HIV Infection,” Am J Health Syst Pharm , 2004, 61(13):1365-74. [PubMed 15287232 ] Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection," August 11, 2011. Available at: file://aidsinfo.nih.gov Topic 12906 Version 48.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-197.136.42.3-EDC393233E-S244013.14]